RE: Dr Jonathan Milner new investor11 Jun 2024 10:17
He's the lead investor on quite a few UK Biotechs and been in them for around 7 years so far investor on other companies board member on others co founder of therapeutics institute chairman
And CURRENT CEO AND FOUNDER OF ABCAM
On 28 August 2023, Danaher Corporation announced that it had entered into a definitive agreement to acquire Abcam for approximately $5.7 billion at $24 per share in cash.[7][8][9] The acquisition was completed on December 6.[10]
LEGEND